Research Conducted at NOVA Southeastern University Has Provided New Information about Hypertension (Sotatercept: the First Fda-approved Activin a Receptor Iia Inhibitor Used In the Management of Pulmonary Arterial Hypertension)

Media coverage

• Title	Research Conducted at NOVA Southeastern University Has Provided New Information about Hypertension (Sotatercept: the First Fda-approved Activin a Receptor Iia Inhibitor Used In the Management of Pulmonary Arterial Hypertension)
  Media name/outlet	CDC & FDA Daily
  Country/Territory	United States
  Date	11/21/24
  Persons	Genevieve M Hale, Huy Pham